Related Experiment Videos
Motor cortex stimulation.
1Department of Neurological Surgery, Wayne State University, School of Medicine, Detroit, Michigan 48201, USA. jbrown@neurosurgery.wayne.edu
Neurosurgical Focus
|March 8, 2006
Summary
Epidural motor cortex stimulation (MCS) offers effective relief for refractory central and neuropathic pain. This neuromodulation technique shows promise in improving patient outcomes and reducing chronic pain suffering.
Area of Science:
- Neurosurgery
- Neurology
- Pain Management
Background:
- Epidural motor cortex stimulation (MCS) was first introduced in 1991 for treating central and neuropathic pain.
- Subsequent research has expanded understanding of MCS indications, techniques, mechanisms, and outcomes.
Purpose of the Study:
- To review the efficacy and safety of epidural motor cortex stimulation for refractory neuropathic pain.
- To explore the hypothesized mechanisms of pain relief and factors influencing outcomes.
Main Methods:
- Review of existing literature on epidural motor cortex stimulation for pain management.
- Analysis of patient outcomes, including pain alleviation and procedure-related morbidity.
- Investigation of neuroimaging findings, such as changes in regional cerebral blood flow.
Main Results:
- Epidural MCS is effective for various neuropathic pain conditions, including trigeminal neuropathy, thalamic pain, and spinal cord injury pain.
- Optimal outcomes are associated with milder motor deficits and trigeminal pain.
- Pain relief correlates with increased blood flow in the ventrolateral thalamus and cingulate gyrus, suggesting reduced suffering.
Conclusions:
- Motor cortex stimulation is an established therapy for complex, medically refractory central and neuropathic pain syndromes.
- While procedure-related morbidities exist, serious complications like seizures have not been observed.
- MCS provides rapid and sustained pain relief, even after stimulation cessation.